Taking place November 2-3, 2022 in Philadelphia, the 3rd Next-Gen MSL Excellence Summit empowers Medical Science Liaisons with all the scientific data tools and customer outreach skills they need to build successful relationships with all stakeholders. The faculty of industry leaders will help attendees refine their approach to Key Opinion Leaders and clearly, convincingly communicate it with patients throughout the product life cycle.
Registering for this event gains you an all-access pass to 3 programs in 1! Attendees can also learn and network in discussions and sessions from the 6th Digital Strategy & Innovation for Medical Affairs Summit or the 2nd Investigator-Initiated Trials Summit.
The event is hosted by Dynamic Global Events (“DGE”), a Life Science leader in organizing b2b events.
Important topics of discussion:
- Discuss and analyze career opportunities and better horizons for MSLs
- Strategic planning for onboarding to offer the best experience to newbies
- Ways to successfully collaborate with cross-functional teams
- Learn unique ways of soft skill MSL management
- Innovative strategies for synchronizing medical affairs with clinical development and commercial teams
- Leverage emotional intelligence to engage KOLs, gather insights and relay scientific information
- Most effective ways to achieve success as an MSL
- Predict future trends for the optimum development and success of MSLs
- Discuss the role of MSL in voicing the patient’s opinion in research and development
MSLs need to learn effective presentation techniques in physical and virtual formats. To help with these needs, at this event industry experts will share tips on correct body language, proper conduct and effective communication skills to ensure that the MSLs engage with the audience.
Special fireside chats will cover ways to elevate the voice of the patient in R&D. Thought leaders will discuss how trauma-informed languages help in medical education as well as shared decision-making and best practices in patient-centric education. The discussions will involve the robust use of digital technology within the organization’s KOL strategy to optimize field engagement, advance scientific partnerships, and better clinical insights.
To learn more, please visit https://ibn.fm/LjmS1.
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.